Document Detail

Effects of restricted fructose access on body weight and blood pressure circadian rhythms.
Jump to Full Text
MedLine Citation:
PMID:  22536215     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
High-fructose diet is known to produce cardiovascular and metabolic pathologies. The objective was to determine whether the timing of high fructose (10% liquid solution) intake affect the metabolic and cardiovascular outcomes. Male C57BL mice with radiotelemetric probes were divided into four groups: (1) 24 h water (control); (2) 24 h fructose (F24); (3) 12 h fructose during the light phase (F12L); (4) 12 h fructose during the dark phase (F12D). All fructose groups had higher fluid intake. Body weight was increased in mice on restricted access with no difference in total caloric intake. Fasting glycemia was higher in groups with restricted access. F24 mice showed a fructose-induced blood pressure increase during the dark period. Blood pressure circadian rhythms were absent in F12L mice. Results suggest that the timing of fructose intake is an important variable in the etiology of cardiovascular and metabolic pathologies produced by high fructose consumption.
Authors:
Danielle Senador; Swapnil Shewale; Maria Claudia Irigoyen; Khalid M Elased; Mariana Morris
Related Documents :
22555255 - Effects of pharyngeal cooling on brain temperature in primates and humans: a study for ...
7038645 - The effect of prostacyclin on some hemodynamic parameters in dogs.
8581205 - The effect of left ventricular dp/dt on the in vitro dynamics of the björk-shiley conve...
22665565 - A salty cause of severe hypertension.
25236305 - Pharmacological interventions for hypertension in children.
9687835 - Indications for peripartum aortic pressure monitoring in takayasu's disease. a patient ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-03-29
Journal Detail:
Title:  Experimental diabetes research     Volume:  2012     ISSN:  1687-5303     ISO Abbreviation:  Exp Diabetes Res     Publication Date:  2012  
Date Detail:
Created Date:  2012-04-26     Completed Date:  2012-07-26     Revised Date:  2013-06-25    
Medline Journal Info:
Nlm Unique ID:  101274844     Medline TA:  Exp Diabetes Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  459087     Citation Subset:  IM    
Affiliation:
Department of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, 3640 Colonel Glenn Highway, Dayton, OH 45435, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Glucose / drug effects*,  metabolism
Blood Pressure / drug effects*
Body Weight / drug effects*
Circadian Rhythm / drug effects*
Drinking / drug effects
Fructose / pharmacology*
Glucose Tolerance Test
Heart Rate / drug effects
Male
Mice
Motor Activity / drug effects
Telemetry
Grant Support
ID/Acronym/Agency:
DK59630/DK/NIDDK NIH HHS; R01HL69319/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 30237-26-4/Fructose
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Exp Diabetes Res
Journal ID (iso-abbrev): Exp Diabetes Res
Journal ID (publisher-id): EDR
ISSN: 1687-5214
ISSN: 1687-5303
Publisher: Hindawi Publishing Corporation
Article Information
Download PDF
Copyright © 2012 Danielle Senador et al.
open-access:
Received Day: 10 Month: 8 Year: 2011
Accepted Day: 16 Month: 11 Year: 2011
Print publication date: Year: 2012
Electronic publication date: Day: 29 Month: 3 Year: 2012
Volume: 2012E-location ID: 459087
ID: 3321444
PubMed Id: 22536215
DOI: 10.1155/2012/459087

Effects of Restricted Fructose Access on Body Weight and Blood Pressure Circadian Rhythms
Danielle Senador1
Swapnil Shewale1
Maria Claudia Irigoyen2
Khalid M. Elased1
Mariana Morris1*
1Department of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, 3640 Colonel Glenn Highway, Dayton, OH 45435, USA
2Heart Institute, School of Medicine, University of São Paulo, 05403-900 São Paulo, SP, Brazil
Correspondence: *Mariana Morris: mariana.morris@wright.edu
[other] Academic Editor: Dulce Elena Casarini

1. Introduction

Given the substantial levels of fructose consumption in our everyday diet, it is important to delineate its consequences [1, 2]. There is compelling evidence that increased fructose intake has metabolic and cardiovascular effects in both human and animals [38]. Our group showed that a high-fructose diet in mice produced glucose intolerance and increased blood pressure [4, 6]. Evidence also showed that sympathetic activation occurred rapidly before fructose induction of metabolic dysfunction [9]. A clinical study showed that ingestion of water containing 60 g of fructose acutely elevates blood pressure in healthy human subjects [3].

In addition to the global detrimental effects of high fructose intake, the timing of consumption might also play a causative role in the metabolic and cardiovascular pathologies. There are many examples of work and lifestyle patterns that require alternative intake cycles. This is seen in public service work: police and fire protection, transportation, and utilities, all of which rely on 24 hr around the clock attention. Likewise, shift work as required in health care or manufacturing industries forces people to be active in the normal sleeping phase of the light-dark (L/D) cycle. Obesity and metabolic syndrome are often associated with the nocturnal eating syndrome and shift work, demonstrating the connection between L/D cycle and metabolic pathologies [1015]. Circadian misalignment has also been shown to produce changes in glucose and insulin levels, as well as increases in blood pressure, in both mice and humans [1618]. Although the mechanisms underlying these adverse cardiometabolic changes remain unknown, it is possible that disturbances in the sleep/wake and eating schedule, could, in turn, influence appetite, food intake, and energy balance. This could have important implications for the increased obesity, diabetes, and cardiovascular disease in the shift work population [15].

In the context of the worldwide epidemic of obesity and diabetes [19], the increase in sugar consumption in our contemporary western diets [20], and the increase in sedentary lifestyles [21], we conducted studies in mice to evaluate the effects of 24 h access to fructose as well as the influence of the timing of consumption (fructose access provided only in the light or dark period). The parameters of interest focused on cardiovascular and metabolic function: 24 hr L/D rhythm in BP, glucose tolerance, plasma insulin, and the pattern and amount of fructose intake.


2. Methods
2.1. Animals, Surgery, and General Procedures

Eight-week-old male C57BL mice (~25 gm, Harlan Inc, Indianapolis, IN) were given water or fructose (10%) for 8 weeks. Groups are (1) 24 h water (Control, n = 6); (2) 24 h fructose (F24, n = 6); (3) 12 h fructose during the light phase (F12L, n = 6); (4) 12 h fructose during the dark phase (F12D, n = 6). Animals were housed at 22°C under a 12/12 light/dark cycle with ad libitum access to standard pellet chow and water or fructose. Telemetric probes (model TA11PA-C10, Data Sciences International, St. Paul, MN) were inserted into the left common carotid artery at 6 weeks in mice anesthetized with ketamine/xylazine (120 : 20 mg/kg, im). The transmitter body was positioned subcutaneously on the right flank [22, 23]. 24 h cardiovascular recordings, fluid, and food consumption measurements were made at 8 wks. Body weight was measured during the 2nd, 4th, and 8th weeks of the experimental protocol.

2.2. Glucose Tolerance Test (GTT)

GTT was performed at the beginning of the 8th week (last week) of the experimental protocol. Mice were fasted, with animals receiving only water, for 6 h. Blood samples were taken from a tail cut at 0, 15, 30, 60, and 90 min after i.p. glucose load (1.5 g/kg). Blood glucose was determined by Accu-Chek Advantage Blood Glucose Monitor (Roche Diagnostic Corporation, Indianapolis, IN).

2.3. Plasma Measurements

At the end of the 8th week of treatment, mice were sacrificed by decapitation and trunk blood was collected in ice-chilled heparinized tubes. Total plasma cholesterol and triglycerides were determined by colorimetric enzymatic assays (Thermo Fisher Scientific Inc., Waltham, MA). Plasma insulin levels were measured using a multianalytic profiling beads assay (Linco Research Inc., St Charles, MO).

2.4. Urinary Corticosterone Measurements

Spot urine samples (100~100 uL) were collected during the last hour of the light phase. Urinary corticosterone levels were measured by radioimmunoassay (MP Biomedical, Orangeburg, NY, USA). Urinary creatinine was measured by spectrophotometry (Microvue Creatinine Assay Kit, Quidel Corporation, San Diego, USA). The corticosterone : creatinine ratio was calculated for each urine specimen.

2.5. Statistics

Values were expressed as mean ± SEM. Data were analyzed using ANOVA two-way or repeated measures when applicable and followed by the Newman-Keuls test. Differences were considered to be statistically significant at P < 0.05.


3. Results

Baseline body weights (BWs) ranged from 26 to 28 g. The percentage increase in BW over the 8 wk period was significantly higher in the restricted access groups (Figure 1). The F12L and F12D groups showed significant increases in BW gain after 8 wks of treatment as compared to 2 wks (P < 0.05). Total caloric intake was not different between groups (Figure 2).

Fluid intake was measured during the light and dark phases with significant effects of diet, light/dark, and interaction between diet and light/dark (Figure 3). 24h fluid intake was higher in F24 and F12D mice when compared to Control group (P < 0.01). There were light/dark differences in intake in Control, F24, and F12D groups. In the F12L group, there was no difference in fluid intake between the light and dark phases. In the restricted access groups, fluid intake was greatest during the fructose consuming period, light for F12L and dark for F12D (P < 0.01 vs. Control). With regard to the percentage fluid intake during light and dark phases, mice consuming fructose during the dark period drank a greater percentage of fluid, 67–74%, during this phase (Table 2). Mice given fructose during the light period drank almost equal amounts during the light and dark (44 and 56% resp.).

Fasting glucose was higher in groups under restricted fructose access as compared to Control (Figure 4(A), P < 0.01) with higher levels in F12L as compared to F12D (Figure 4(A), P < 0.01). GTT showed impaired glucose tolerance in F24 and F12L groups as compared to control (Figure 4(B), P < 0.01).

There were no significant changes in insulin levels among groups (Table 1). Triglyceride levels were lower in restricted fructose access groups (Table 1, P < 0.01). Both plasma cholesterol and urinary corticosterone levels showed no difference among the groups (Table 1).

Light/dark differences in BP were present in Control, F24, and F12D groups (Figure 5(A), P < 0.05). The circadian BP rhythm was not seen in the F12L (Figure 5(A)). Fructose consumption produced an increase in BP in the F24 group during the dark phase when compared to the Control group during the same phase (Figure 5(A), P < 0.05) and also when compared to F24 during the light phase (Figure 5(A), P < 0.05). This fructose effect was not observed in the F12D group (Figure 5(A)). All groups showed elevated HR during the dark as compared to the light phase (Figure 5(B), P < 0.05) with no effect of the fructose regimen (Figure 5(B)).


4. Discussion

The increase in fructose consumption, due to its widespread presence in the modern diet, has become a major public health concern. This is related to evidence that excessive fructose intake may have detrimental effects, including the promotion of obesity and its cardiovascular and metabolic complications [1, 2]. Studies focused on the direct effects of fructose intake in animals and humans showed increased BP, dyslipidemia, insulin resistance, and glucose intolerance [38]. In addition to the detrimental effects of a high-fructose diet, the timing of consumption might have additional effects. Changes in circadian feeding patterns, such as the night eating syndrome (NES), can promote weight gain, hormonal changes, and psychological disorders in either in animals or humans [1014, 24]. In this study, we evaluated the time effect (light or dark) of fructose consumption on BP, body weight, and metabolic and hormonal parameters. We observed that day or night restricted fructose consumption increased body weight gain and glycemia. Further changes were observed in mice submitted to light-restricted fructose access: glucose intolerance, exacerbated hyperglycemia, and a lack of circadian BP oscillation. These additional changes were observed after 8 weeks of treatment, suggesting that the chronic aspect of the restricted regimen itself might be responsible, at least partially, for these results.

The circadian BP rhythm refers to the daily variation in BP that in humans shows higher levels during day vs. night. Healthy subjects usually present a 10–20% decline in arterial BP during nighttime intervals which is called the “dipper” pattern [25]. Impaired nocturnal BP decline (nondipping) is a BP abnormality that is frequently seen among patients with diabetes [2630]. In order to follow the L/D BP rhythm in our study, we used radiotelemetry for BP monitoring in conscious, undisturbed mice. 24 hr BP recordings showed, as expected, that control mice exhibited light/dark circadian oscillations with lower BP seen during the light period, the inactive period for mice [4, 3133]. When fructose access was restricted to the light phase (F12L), the light/dark BP rhythm was nonexistent. This could be related, at least partly, to the drinking pattern since the F12L group also showed a lack of circadian oscillation in fluid intake, that is, similar levels during the light and dark periods. This indicates that animals spent more time, during the light phase, drinking and therefore awake and possibly active. Blood pressure circadian rhythm disruption may also be due to changes in sleep since it has been observed in diabetic patients, who wake up more frequently during the night (for instance, due to nocturia) [34]. Although sleep disruption may also be associated with stress [35], stress as documented by unchanged urinary corticosterone does not seem to be responsible for the observed cardiovascular and metabolic effects. Therefore, the disturbance in circadian BP pattern in the F12L group might be due to the timing of fructose ingestion (during the light phase) itself. Possibly, a higher fructose load or longer treatment could produce a shift in the BP circadian pattern in the F12L. However, these speculations do not affect the conclusion drawn from this group: fructose access restricted to the light phase produces disruption in BP rhythms.

The circadian pattern on HR light/dark oscillations, showing a rhythmic pattern of variation in HR during 24 hours characterized by higher HR in the dark (awake period) over the light period (sleep period), was not affected by any of the treatments. As previously shown by our group [4, 22], although nocturnal BP was increased in F24 when compared to controls, no further changes due to fructose were observed in HR.

Circadian changes, such as the nondipping BP pattern, are associated with diabetic micro- and macrovascular [3641] complications and end-organ damage [42]. The circadian changes in BP and fluid intake observed in F12L could also be implicated in the impaired glucose metabolism (exacerbated hyperglycemia and glucose intolerance), exclusively observed in this group (F12L). Preliminary information suggests derangements in renal histology in mice with fructose access restricted to the light phase (Morris et al., unpublished data). Changes in circadian pattern of food consumption can lead to weight gain, metabolic dysfunction [1014, 43], and increased risk of obesity and diabetes [44] in humans. The light phase-restricted fructose drinking regimen could be a parallel for human NES, which is associated with hyperglycemia, glucose intolerance [45], and weight gain without changes in total caloric consumption [12, 46], similar to our observations in mice. Although the mechanism behind light-fed weight gain in mice is unknown, the study of Arble et al., showed that there is causal evidence that feeding at the “wrong” time can lead to weight gain [10].

Although F12L mice showed greater impairment in glucose handling, both groups on restricted fructose access (F12L and F12D) showed increased BW gain and hyperglycemia, not observed in the F24 group. Chronic misalignments between endogenous circadian timing system and behavioral cycles have adverse metabolic effects in humans [43], including increased risk of obesity and diabetes [44]. As shown by our group [4, 6], 24 h access to fructose produces glucose intolerance without increases in BW. Therefore, the circadian restriction aspect of the drinking regimen itself could contribute to the increase in weight gain and blood glucose levels observed in F12L and F12D.

A high-fructose diet in rodents has been associated with cardiovascular dysregulation and insulin resistance [4, 6, 4749], More specifically, increased fructose intake, in both, animals and humans, increases blood pressure and causes dyslipidemia and changes in glucose handling [38]. As expected, mice receiving fructose 24 h a day exhibited nocturnal hypertension [4, 6]. However, BP was not increased in groups on restricted fructose access (F12L and F12D) despite the circadian disruption observed in the F12L group. Diet concentration and length of treatment are important factors for hypertension development in the rodent fructose model [50]. Therefore, the restricted aspect of the fructose access regimen itself could be a possible explanation for the absence of BP increase in the F12L and F12D groups.

As mentioned previously, fructose consumption is often associated with dyslipidemia. Chronic consumption of fructose led to hypercholesterolemia without changes in plasma triglycerides [4, 6, 51, 52]. However, in this study, the F24 group showed no changes in cholesterol. This could be due to the nature of the fructose source, since in previous studies [4, 6] fructose was given in the chow (pellet diet containing 67% carbohydrate—98% fructose, 13% fat, and 20% protein) instead of as a fluid (10% fructose solution). Both groups on restricted access (F12L and F12D) had lower levels of triglycerides with no changes in cholesterol. Since circulating factors such as glucose and triglycerides can be modulated by time-restricted food intake access [13, 53], the restricted nature of the fructose drinking regimen itself could explain the results observed in these groups.


5. Conclusion

In conclusion, we demonstrated that circadian phase restriction of fructose access leads to changes in glucose homeostasis, body weight gain, and light/dark BP rhythms. The data suggests that even moderate circadian changes might contribute to the onset or development of the metabolic syndrome symptoms, which might be exacerbated by the timing of fructose consumption. The results have clinical implications since time of day and intake may be considered in the overall treatment regimen.


Acknowledgments

The authors acknowledge the financial support of the NIH R01HL69319 (M. Morris and K. M. Elased), the AHA Scientist Development Grant 0735112 N (K. M. Elased). D. Senador was supported by Foundation for the Improvement of Postsecondary Education, PhD Exchange Program (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Programa de Doutorado com Estágio no Exterior, CAPES/PDEE Process 010405-1). The authors also gratefully acknowledge the help of Cincinnati Mouse Metabolic Phenotyping Center (DK59630), Vera Farah, and Nathan Weir.


References
1. Elliott SS,Keim NL,Stern JS,Teff K,Havel PJ. Fructose, weight gain, and the insulin resistance syndromeThe American Journal of Clinical NutritionYear: 200276591192212399260
2. Bray GA,Nielsen SJ,Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesityThe American Journal of Clinical NutritionYear: 200479453754315051594
3. Brown CM,Dulloo AG,Yepuri G,Montani JP. Fructose ingestion acutely elevates blood pressure in healthy young humansAmerican Journal of PhysiologyYear: 20082943R730R73718199590
4. Farah V,Elased KM,Chen Y,et al. Nocturnal hypertension in mice consuming a high fructose dietAutonomic NeuroscienceYear: 20061301-2415016843071
5. Furuhashi M,Ura N,Takizawa H,et al. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivityJournal of HypertensionYear: 200422101977198215361770
6. Senador D,Key M,Brosnihan KB,Irigoyen MC,Elased KM,Morris M. Cardiovascular interactions between losartan and fructose in miceJournal of Cardiovascular Pharmacology and TherapeuticsYear: 2010151687719995939
7. Shinozaki K,Ayajiki K,Nishio Y,Sugaya T,Kashiwagi A,Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistanceHypertensionYear: 200443225526214698997
8. Teff KL,Grudziak J,Townsend RR,et al. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responsesJournal of Clinical Endocrinology and MetabolismYear: 20099451562156919208729
9. de Angelis K,Senador DD,Mostarda CT,Irigoyen MC,Morris M. Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice American Journal of Physiology. In press.
10. Arble DM,Bass J,Laposky AD,Vitaterna MH,Turek FW. Circadian timing of food intake contributes to weight gainObesityYear: 200917112100210219730426
11. Bodosi B,Gardi J,Hajdu I,Szentirmai E,Obal F Jr.,Krueger JM. Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivationAmerican Journal of PhysiologyYear: 20042875R1071R107915475503
12. Colles SL,Dixon JB,O’Brien PE. Night eating syndrome and nocturnal snacking: association with obesity, binge eating and psychological distressInternational Journal of ObesityYear: 200731111722173017579633
13. Kudo T,Akiyama M,Kuriyama K,Sudo M,Moriya T,Shibata S. Night-time restricted feeding normalises clock genes and Pai-1 gene expression in the db/db mouse liverDiabetologiaYear: 20044781425143615309293
14. Zvonic S,Ptitsyn AA,Conrad SA,et al. Characterization of peripheral circadian clocks in adipose tissuesDiabetesYear: 200655496297016567517
15. Åkerstedt T,Kecklund G,Johansson SE. Shift work and mortalityChronobiology InternationalYear: 20042161055106115646250
16. Scheer FAJL,Hilton MF,Mantzoros CS,Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignmentProceedings of the National Academy of Sciences of the United States of AmericaYear: 2009106114453445819255424
17. Ando H,Kumazaki M,Motosugi Y,et al. Impairment of peripheral circadian clocks precedes metabolic abnormalities in ob/ob miceEndocrinologyYear: 201115241347135421285316
18. Okamura H,Doi M,Yamaguchi Y,Fustin J-M. Hypertension due to loss of clock: novel insight from the molecular analysis of Cry1/Cry2-deleted miceCurrent Hypertension ReportsYear: 201113210310821286865
19. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genesDiabetes CareYear: 20113461249125721617109
20. Hofmann SM,Tschöp MH. Dietary sugars: a fat differenceJournal of Clinical InvestigationYear: 200911951089109219422101
21. Lakka TA,Bouchard C. Physical activity, obesity and cardiovascular diseasesHandbook of Experimental PharmacologyYear: 200517013716316596798
22. Farah V,Elased KM,Morris M. Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose dietAmerican Journal of PhysiologyYear: 20072932H1083H108917449556
23. Wichi RB,Farah V,Chen Y,Irigoyen MC,Morris M. Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertensionAmerican Journal of PhysiologyYear: 20072923R1184R118917122330
24. Morris M,Araujo IA,Pohlman RL,Marques MC,Rodwan NS,Farah V. Timing of fructose intake: an important regulator of adiposityClinical and Experimental Pharmacology and PhysiologyYear: 2012391576222032284
25. Pierdomenico SD,Lapenna D,Guglielmi MD,et al. Arterial disease in dipper and nondipper hypertensive patientsAmerican Journal of HypertensionYear: 1997105, part 15115189160761
26. Chau NP,Bauduceau B,Chanudet X,Larroque P,Gautier D. Ambulatory blood pressure in diabetic subjectsAmerican Journal of HypertensionYear: 1994764874917917144
27. Fogari R,Zoppi A,Malamani GD,Lazzari P,Destro M,Corradi L. Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetics: prevalence of impaired diurnal blood pressure patternsAmerican Journal of HypertensionYear: 199361178427656
28. Ikeda T,Matsubara T,Sato Y,Sakamoto N. Circadian blood pressure variation in diabetic patients with autonomic neuropathyJournal of HypertensionYear: 19931155815878390531
29. Rutter MK,McComb JM,Forster J,Brady S,Marshall SM. Increased left ventricular mass index and nocturnal systolic blood pressure in patients with type 2 diabetes mellitus and microalbuminuriaDiabetic MedicineYear: 200017432132510821300
30. Wiegmann TB,Herron KG,Chonko AM,MacDougall ML,Moore WV. Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitusDiabetesYear: 19903912155615602245880
31. Chen D,La LG,Head GA,Walther T,Mayorov DN. The day-night difference of blood pressure is increased in AT1A-receptor knockout mice on a high-sodium dietAmerican Journal of HypertensionYear: 201023548148720168304
32. Sheward WJ,Naylor E,Knowles-Barley S,et al. Circadian control of mouse heart rate and blood pressure by the suprachiasmatic nuclei: behavioral effects are more significant than direct outputsPloS ONEYear: 201053 Article ID e9783..
33. Senador D,Kanakamedala K,Irigoyen MC,Morris M,Elased KM. Cardiovascular and autonomic phenotype of db/db diabetic miceExperimental PhysiologyYear: 200994664865819218356
34. Perk G,Mekler J,Ben ID,Bursztyn M. Non-dipping in diabetic patients: insights from the siestaJournal of Human HypertensionYear: 200216643543812037701
35. Heinrichs SC,Koob GF. Application of experimental stressors in laboratory rodentsCurrent Protocols in Neuroscience chapter 8, unit 8.4, 2006.
36. Hansen HP,Rossing P,Tarnow L,Nielsen FS,Jensen BR,Parving HH. Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathyKidney InternationalYear: 19965025795858840289
37. Knudsen SO,Poulsen PL,Hansen KWÜ,Ebbehøj E,Bek T,Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetesAmerican Journal of HypertensionYear: 200215324425011939615
38. Knudsen ST,Jeppesen P,Frederiksen CA,et al. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in type 2 diabetic subjectsDiabetic MedicineYear: 200724891191517559428
39. Nakano S,Fukuda M,Hotta F,et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjectsDiabetesYear: 1998479150115069726241
40. Nakano Y,Oshima T,Ozono R,et al. Non-dipper phenomenon in essential hypertension is related to blunted nocturnal rise and fall of sympatho-vagal nervous activity and progress in retinopathyAutonomic NeuroscienceYear: 200188318118611474560
41. Nielsen FS,Rossing P,Bang LE,et al. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathyDiabetesYear: 19954477837897789646
42. Spallone V,Maiello MR,Cicconetti E,et al. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetesJournal of Human HypertensionYear: 200115423924611319671
43. Kohsaka A,Bass J. A sense of time: how molecular clocks organize metabolismTrends in Endocrinology and MetabolismYear: 200718141117140805
44. Kroenke CH,Spiegelman D,Manson J,Schernhammer ES,Colditz GA,Kawachi I. Work characteristics and incidence of type 2 diabetes in womenAmerican Journal of EpidemiologyYear: 2007165217518317071844
45. Qin LQ,Li J,Wang Y,Wang J,Xu JY,Kaneko T. The effects of nocturnal life on endocrine circadian patterns in healthy adultsLife SciencesYear: 200373192467247512954455
46. Allison KC,Ahima RS,O’Reardon JP,et al. Neuroendocrine profiles associated with energy intake, sleep, and stress in the night eating syndromeJournal of Clinical Endocrinology and MetabolismYear: 200590116214621716131578
47. Dai S,Todd ME,Lee S,McNeill JH. Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic ratsCanadian Journal of Physiology and PharmacologyYear: 19947277717817828085
48. Delbosc S,Paizanis E,Magous R,et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed ratAtherosclerosisYear: 20051791434915721008
49. Hwang I,Ho H,Hoffman BB,Reaven GM. Fructose-induced insulin resistance and hypertension in ratsHypertensionYear: 19871055125163311990
50. Dai S,McNeill JH. Fructose-induced hypertension in rats is concentration- and duration-dependentJournal of Pharmacological and Toxicological MethodsYear: 19953321011077766916
51. Ostos MA,Recalde D,Baroukh N,et al. Fructose intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV transgenic miceJournal of NutritionYear: 2002132591892311983814
52. Nagata R,Nishio Y,Sekine O,et al. Single nucleotide polymorphism (-468 Gly to Ala) at the promoter region of sterol regulatory element-binding protein-1c associates with genetic defect of fructose-induced hepatic lipogenesisJournal of Biological ChemistryYear: 200427928290312904215123654
53. Oishi K,Ohkura N,Kasamatsu M,et al. Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetesThrombosis ResearchYear: 2004114212913515306155

Article Categories:
  • Research Article


Previous Document:  Comparison of oxidant/antioxidant, detoxification systems in various tissue homogenates and mitochon...
Next Document:  Regenerative therapies for diabetic microangiopathy.